BioHealth News Archive
On Demand Pharmaceuticals Appoints Jarrod Borkat, MBA, as Chief Strategy and Commercial Officer
Rockville, MD, United States, October 22, 2024 — On Demand Pharmaceuticals (ODP), a pioneering leader in agile distributed medicine manufacturing, is thrilled to announce the…
Read More
Linshom Medical Announces FDA Clearance of the Company’s 2nd Generation Respiratory Sensor
BALTIMORE, MD, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Linshom Medical announced today U.S. Food and Drug Administration, 510(k), clearance of the company’s two-piece, wearable respiratory…
Read More
CES2025: How “AgeTech” Is Empowering Wellbeing, Through the Eyes of BHI’s John Reinhart
CES2025 once again brought the world’s brightest minds and groundbreaking innovations to Las Vegas. With over 4,500 exhibitors and more than 141,000 attendees, the…
Read More
TEDCO Invests in NanoBioFAB
Maryland-based medical device company receives investment from Pre-Seed Builder Fund. COLUMBIA, Md., (January 20, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
UVA Today: Biotech Accelerator To Launch in Charlottesville
By Bethanie Glover, ffu4bm@virginia.edu January 15, 2025 - The commonwealth’s biotechnology and innovation footprint is expanding, thanks to an award from the state’s GO…
Read More
TEDCO Selects AIN to Support Management and Investment of Allocated SSBCI Funding
AIN becomes the second selected VCLP to support the next generation of technology innovation COLUMBIA, Md., (January 15, 2025) — TEDCO, Maryland’s economic engine…
Read More
CvilleBioHub Enters Into A Virginia Collaboration Network And Will Launch New Biotech Accelerator In Charlottesville
GO Virginia, University of Virginia, Manning Family Foundation, and local Economic Development support the three-year project driving life sciences entrepreneurship. Charlottesville, VA (January 14, 2025) --- The…
Read More
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
ROCKVILLE, Md., Jan. 14, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) and Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) today announced a strategic partnership for the development and commercialization…
Read More
EMBL: Researchers uncover what drives aggressive bone cancer
January 14, 2025 - Vicky Hatch - Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the…
Read More
VA Tech Research: Words activate hidden brain processes shaping emotions, decisions, and behavior
In an unprecedented new study in the journal Cell Reports, researchers have shown neurotransmitters in the human brain are released during the processing of the…
Read More
State of Maryland, University of Maryland Announce $1 Billion “Capital of Quantum” Initiative
COLLEGE PARK, Md., January 14, 2025--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leader in the quantum computing and networking industries, today announced a landmark partnership with…
Read More
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive…
Read More
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
NORTH CHICAGO, Ill. and ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program. ABBV-RGX-314 in Wet…
Read More
Novavax is Powering the Future of Vaccines Through R&D and Value-creating Business Strategy
January 13, 2025 - By Ruxandra Draghia-Akli, MD, PhD, Executive Vice President, Head of R&D and Elaine O’Hara, Executive Vice President, Chief Strategy Officer As…
Read More
VEDP: Booming Virginia clusters provide a supply chain blueprint for increasing drug accessibility, affordability
Like his fellow Type 1 diabetics, Alec Smith took insulin every day to regulate his blood sugar. Costs to treat his condition topped $1,000…
Read More